ICOone wins innovation award
Iconovo won the Lund University Innovation Award. The winning project was "ICOone for inhaled vaccines". Vaccines are currently administered as injections,…
ICOone in the finals to win innovation award
Iconovo is in the finals to win the Lund University Innovation Award. ICOone for inhaled vaccine was presented to the jury and judged on the level of innovation…
Connectivity in Medical Technology – Electronics in ICOone and ICOres
Iconovo CEO Dr Orest Lastow will speak at Connectivity in Medical Technology organized by Management Forum in London 24-25 June. The speach is titled "The…
Injection molded ICOcap
The development of Iconovo's proprietary capsule based inhaler, ICOcap has reached an important milestone. The first mold tools have been manufactured…
Pulmonary Drug Delivery: Advances and Challenges
Orest Lastow is the co-author of a recently published book titled "Pulmonary Drug Delivery: Advances and Challenges". The book addresses problems associated…
Management Forum – Dry Powder Inhalers
Iconovo CEO Dr Orest Lastow has been invited to give a presentation about the Iconovo inhalation devices at the Dry Powder Inhaler Conference organized…
New Updates in Drug Formulation and Bioavailability
Iconovo´s CEO Dr Orest Lastow will be moderating the New Updates in Drug Formulation and Bioavailability conference in Copenhagen 7 April. Formulation…
Computational Fluid Dynamics, CFD
Iconovo has invested in the Autodesk Simulation CFD software. Iconovo CEO Dr Orest Lastow was previously head of the AstraZeneca CFD group and has long…
New lab facilities
Iconovo has moved into new lab facilities. The new facilities will allow us to perform verification and performance testing of the devices in development.…
Published paper in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Iconovo CEO Dr Orest Lastow has published a paper in Journal of Aerosol Medicine and Pulmonary Drug Delivery. The paper is titled “Orally Inhaled Drug…
